The Distribution Volume of 18F-Albumin as a Potential Biomarker of Antiangiogenic Treatment Efficacy-Reference-Cited by-同舟云学术

The Distribution Volume of 18F-Albumin as a Potential Biomarker of Antiangiogenic Treatment Efficacy

Published:2019-05 Issue:4 Volume:34 Page:238-244
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Roy Jyoti¹,Kuo Frank¹,Basuli Falguni²,Williams Mark R.¹,Wong Karen¹,Green Michael V.¹³,Seidel Jurgen¹³,Adler Stephen S.¹,Xu Biying²,Choyke Peter L.¹,Jagoda Elaine M.¹

Affiliation:

1. Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

2. Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, Maryland.

3. Contractor to Leidos Biomedical Research, Inc. (formerly SAIC-Frederick Inc.), NCI-Frederick, Frederick, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2018.2656

Reference28 articles.

1. Tumor Angiogenesis: Therapeutic Implications

2. Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch

3. Angiogenesis in life, disease and medicine

4. Oncologic angiogenesis imaging in the clinic: how and why?

5. Angiogenesis Imaging in Neoplasia

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new automated and putatively versatile synthesis of the PSMA-ligand derivative [18F]DCFPyL using the FASTlabTM synthesizer;EJNMMI Radiopharmacy and Chemistry;2022-05-04